Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs 5,427
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Pipeline programs

Page 39 of 114

  1. EFC17215 - LEAP2MONO

    Sanofi-aventis Healthcare Pty Ltd

    Gaucher's disease type III

    phase 3 small molecule active

    1 trial

  2. EFC17236

    Sanofi-aventis Healthcare Pty Ltd

    Polyneuropathy, Inflammatory Demyelinating, Chronic

    phase 3 small molecule active

    1 trial

  3. EFC17359

    Sanofi-aventis Healthcare Pty Ltd

    Immune system diseases

    phase 3 other active

    1 trial

  4. EFC17360 - LUMINA 3

    Sanofi-aventis Healthcare Pty Ltd

    Autoimmune haemolytic anaemia

    phase 3 small molecule active

    1 trial

  5. EFC17559

    Sanofi-aventis Healthcare Pty Ltd

    Dermatitis atopic

    phase 3 small molecule active

    1 trial

  6. EFC17560

    Sanofi-aventis Healthcare Pty Ltd

    Dermatitis atopic

    phase 3 small molecule active

    1 trial

  7. EFC17561

    Sanofi-aventis Healthcare Pty Ltd

    Dermatitis atopic

    phase 3 small molecule active

    1 trial

  8. EFC17599 - AQUA

    Sanofi-aventis Healthcare Pty Ltd

    Dermatitis atopic

    phase 3 small molecule active

    1 trial

  9. EFC17600

    Sanofi-aventis Healthcare Pty Ltd

    atopic dermatitis

    phase 3 small molecule active

    1 trial

  10. EFC17757

    Sanofi-aventis Healthcare Pty Ltd

    chronic graft versus host disease

    phase 3 small molecule active

    1 trial

  11. EFC17872

    Sanofi-aventis Healthcare Pty Ltd

    Blood and lymphatic diseases

    phase 3 small molecule active

    1 trial

  12. EFC17919A

    Sanofi-aventis Healthcare Pty Ltd

    multiple sclerosis

    phase 3 other active

    1 trial

  13. EFC17919B

    Sanofi-aventis Healthcare Pty Ltd

    multiple sclerosis

    phase 3 small molecule active

    1 trial

  14. EFC18156

    Sanofi-aventis Healthcare Pty Ltd

    Chronic Inflammatory Demyelinating Polyneuropathy

    phase 3 small molecule active

    1 trial

  15. EFC18554

    Sanofi-aventis Healthcare Pty Ltd

    Kidney transplant rejection

    phase 3 small molecule active

    1 trial

  16. EFC6125

    Regeneron UK Limited

    Ovarian Neoplasms

    phase 3 small molecule completed

    2 trials

  17. EFG PH20 SC

    argenx

    Active Idiopathic Inflammatory Myopathy

    phase 3 mab active

    1 trial

  18. EFGARTIGIMOD ALFA, JNJ-80202135

    Janssen-Cilag International N.V.

    generalized myasthenia gravis

    phase 3 small molecule active

    1 trial

  19. EIK1001

    Eikon Therapeutics

    Advanced Melanoma

    phase 3 small molecule active

    1 trial

  20. EIK1001

    Eikon Therapeutics

    Non Small Cell Lung Cancer (Squamous or Non Squamous)

    phase 3 small molecule active

    1 trial

  21. EIK1001-006

    Eikon Therapeutics

    Advanced Melanoma

    phase 3 small molecule active

    1 trial

  22. ELRANATAMAB

    Pfizer Australia Pty Ltd

    Multiple myeloma

    phase 3 small molecule active

    1 trial

  23. ELX/TEZ/IVA

    Vertex Pharmaceuticals (Australia) Pty.

    Cystic Fibrosis

    phase 3 small molecule completed

    19 trials

  24. EMERALD-1

    AstraZeneca AB

    Locoregional Hepatocellular Carcinoma (HCC)

    phase 3 small molecule active

    1 trial

  25. EMN20

    Fondazione Telethon ETS

    PATIENTS WITH NEW DIAGNOSIS MULTIPLE MYELOMA WITH AGE >= 65 YEARS OR NOT ELIGIBLE TO ASCT

    phase 3 small molecule active

    1 trial

  26. ENCITJ-GC01

    Eastern Hepatobiliary Surgery Hospital

    Gastric Cancer

    phase 3 small molecule terminated

    1 trial

  27. ENGIC 06 FRUQUITAS

    CERO THERAPEUTICS HOLDINGS, INC.

    metastatic oeso-gastric adenocarcinoma

    phase 3 small molecule active

    1 trial

  28. ENOXAPARIN

    Pari Pharma GmbH

    Allograft vascular thrombosis

    phase 3 small molecule active

    1 trial

  29. EORTC-2238-GUCG

    Ningbo Cancer Hospital

    Metastatic hormone naïve prostate cancer (mHNPC)

    phase 3 small molecule active

    1 trial

  30. EORTC-2427-BTG

    Ningbo Cancer Hospital

    ​​IDH-mutant grade 2 or 3 astrocytoma​

    phase 3 small molecule active

    1 trial

  31. EP0162

    Lacuna Pharma Pty Ltd

    Stereotypical prolonged seizure

    phase 3 small molecule active

    1 trial

  32. EP0165

    Lacuna Pharma Pty Ltd

    Treatment of stereotypical prolonged seizure

    phase 3 small molecule active

    1 trial

  33. EP0224

    Lacuna Pharma Pty Ltd

    Childhood Absence Epilepsy, Juvenile Absence Epilepsy

    phase 3 small molecule active

    1 trial

  34. EPREX®

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Renal Anemia

    phase 3 small molecule completed

    1 trial

  35. ERYTHROPOIETIN , Elritercept

    Takeda

    Myelodysplastic neoplasms/syndromes (MDS)

    phase 3 small molecule active

    1 trial

  36. ETC-1002

    Esperion Therapeutics

    Hypercholesterolemia

    phase 3 small molecule completed

    6 trials

  37. ETEPLIRSEN (AVI-4658)

    Sarepta Therapeutics

    Duchenne Muscular Dystrophy

    phase 3 small molecule active

    1 trial

  38. ETIDRONATE DISODIUM ORAL CAPSULES 400 MG

    Disc Medicine

    Pseudoxanthoma Elasticum

    phase 3 small molecule active

    1 trial

  39. ETOP25-23 ADOPT-lung

    Partner Therapeutics Limited

    Stage IIB-IIIB (N2) resectable non small cell lung cancer

    phase 3 small molecule active

    1 trial

  40. ETOPOSIDE

    Pari Pharma GmbH

    Hemophagocytic lymphohistiocytosis (HLH)

    phase 3 small molecule active

    1 trial

  41. ETOPOSIDE , DEXAMETHASONE

    Pari Pharma GmbH

    Hemophagocytic lymphohistiocytosis (HLH)

    phase 3 small molecule active

    1 trial

  42. ETOPOSIDE - Usual

    Lxo Ireland Designated Activity Company

    Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  43. ETSKABI

    Alphapharm Pty Ltd

    Scabies

    phase 3 small molecule active

    1 trial

  44. EV/DNG (Qlaira, BAY86-5027)

    Bayer HealthCare AG

    Oral Contraceptive

    phase 3 small molecule completed

    1 trial

  45. EVEROLIMUS

    Novartis Pharmaceuticals

    Refractory seizures associated with tuberous sclerosis complex

    phase 3 small molecule active

    1 trial

  46. EVO100

    Evofem Biosciences

    Sexually Transmitted Diseases

    phase 3 small molecule completed

    1 trial

  47. EVO100

    Evofem Biosciences

    Chlamydia Trachomatis Infection

    phase 3 small molecule completed

    1 trial

  48. EXPAREL

    Pacira Ireland Limited

    Total Ankle Arthroplasty

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.